Stay updated on DCVax-L for Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.

Latest updates to the DCVax-L for Newly Diagnosed GBM Clinical Trial page
- Check2 days agoChange DetectedThe page shows a new revision entry (v3.3.4) and removal of the previous revision (v3.3.3). Core study information remains unchanged.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedNew recruitment sites across numerous US states and international locations were added. Several existing sites were removed.SummaryDifference2%

- Check52 days agoChange DetectedThe Publications section now notes items are automatically filled from PubMed and may not be about the study, and the page revision is updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check59 days agoChange DetectedDeleted a general notice regarding government funding and NIH operating status from the page; it is an administrative message not specific to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check73 days agoChange DetectedNo significant differences were observed between the old and new screenshots; the page content and layout appear unchanged.SummaryDifference0.2%

- Check102 days agoChange DetectedUpdated operating-status notice and a new version (v3.2.0) with removal of the previous version tag (v3.1.0).SummaryDifference2%

Stay in the know with updates to DCVax-L for Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.